Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Inaugural 'Korea Medical Innovation Research Forum' regular seminar, a success 2024-04-19 21:00
Concord Medical Files 2023 Annual Report on Form 20-F 2024-04-19 20:31
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024 2024-04-19 19:00
GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer 2024-04-19 19:00
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization 2024-04-19 13:17
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization 2024-04-19 10:54
Cognivia Secures Strategic 15.5M€ Funding to Empower Drug Development with AI-ML Solutions 2024-04-18 21:00
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine 2024-04-18 20:00
European Wellness Leads Pioneering Down Syndrome Research at Heidelberg University 2024-04-18 16:17
Siriraj Hospital Shines Spotlight on TAVI Procedure as Alternative for High-Risk Patients Requiring Aortic Valve Replacement 2024-04-18 15:01
TaiGen Successfully Completes TG-1000 Phase III Study 2024-04-18 11:03
Mini brains and lab-on-a-chip wearables: Jumar Bioincubator officially begins its mission to build "Australia's next CSL" 2024-04-18 11:00
Datasea Secures Combined $15 Million with its Second Sales Contract for Acoustic Products 2024-04-17 22:00
Henlius Releases 2023 ESG Report: Pursuing Sustainable Development with Patient-centricity 2024-04-17 20:32
Q1 2024 Revenue and Business Update 2024-04-17 15:05
World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders" 2024-04-17 15:00
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIA 2024-04-17 14:03
GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY LED INITIATIVES IN ASIA 2024-04-17 11:22
SCG CELL THERAPY AND A*STAR LAUNCH JOINT LABS WITH COLLABORATION NEARING S$30 MILLION TO ADVANCE iPSC TECHNOLOGY TOWARDS SCALABLE GMP MANUFACTURING OF CELLULAR IMMUNOTHERAPIES 2024-04-17 10:00
Kind Pharmaceuticals Announces Settlement 2024-04-17 00:17
1 7.5 8.5 9.5 10.5 11.5 896